Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paroxetine for refractory rosacea
ChiCTR2000031479Phase 4Not yet recruiting
- Sponsor
- Xiangya Hospital, Central South University
- Start
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of paroxetine in rosacea (2 arms), sponsored by Xiangya Hospital, Central South University. Primary endpoint: Assessment of clinical severity of rosacea. Planned start Jan 2020; status: not yet recruiting.
02
Drugs
paroxetine
03
Conditions
rosacea
Beyond the preview
Go deeper on ChiCTR2000031479.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000031479.